Detalhe da pesquisa
1.
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents.
Blood
; 141(22): 2727-2737, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36857637
2.
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Blood
; 139(3): 413-423, 2022 01 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34570876
3.
Emerging immunotherapies in the Hodgkin lymphoma armamentarium.
Expert Opin Emerg Drugs
; : 1-13, 2024 May 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38676917
4.
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Blood
; 138(3): 213-220, 2021 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34292324
5.
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Am J Hematol
; 98(3): 464-471, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36629030
6.
The Genome-Wide Binding Profile for Human RE1 Silencing Transcription Factor Unveils a Unique Genetic Circuitry in Hippocampus.
J Neurosci
; 41(31): 6582-6595, 2021 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34210779
7.
Current Frontline Treatment of Diffuse Large B-Cell Lymphoma.
Oncology (Williston Park)
; 36(1): 51-58, 2022 01 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35089671
8.
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.
Br J Haematol
; 191(1): 44-51, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32430944
9.
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.
Oncologist
; 25(10): 878-885, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32720734
10.
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma.
Oncologist
; 25(6): e993-e997, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32275786
11.
Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma.
Br J Haematol
; 184(1): 17-29, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30485408
12.
Increased double-negative αß+ T-cells reveal adult-onset autoimmune lymphoproliferative syndrome in a patient with IgG4-related disease.
Haematologica
; 107(1): 347-350, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34474549
13.
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Blood
; 123(6): 809-21, 2014 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-24227816
14.
Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy.
Cancers (Basel)
; 15(18)2023 Sep 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37760478
15.
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.
Blood Adv
; 7(21): 6630-6638, 2023 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37595053
16.
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
Blood Adv
; 7(23): 7295-7303, 2023 12 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37729621
17.
GATA2 deficiency underlying severe blastomycosis and fatal herpes simplex virus-associated hemophagocytic lymphohistiocytosis.
J Allergy Clin Immunol
; 137(2): 638-40, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26395816
18.
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
Clin Lymphoma Myeloma Leuk
; 22(7): e435-e442, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35093285
19.
CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
Arch Pathol Lab Med
; 145(6): 753-758, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32991677
20.
Pulmonary Manifestations of GATA2 Deficiency.
Chest
; 160(4): 1350-1359, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34089740